Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Chronic Myeloproliferative Disorders|Gestational Trophoblastic Tumor|Kidney Cancer|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Neuroblastoma|Ovarian Cancer|Testicular Germ Cell Tumor
Interventions: BIOLOGICAL: recombinant interleukin-12
Sponsor: Indiana University School of Medicine
Collaborators: National Cancer Institute (NCI)